NCT01065233 (CDCHC) is a clinical trial of DNA extraction in Alcoholic Cirrhosis, sponsored by Nantes University Hospital.

Who is sponsoring NCT01065233?

NCT01065233 is sponsored by Nantes University Hospital.

What drugs are being tested in NCT01065233?

Interventions in NCT01065233: DNA extraction.

What condition does NCT01065233 study?

NCT01065233 studies Alcoholic Cirrhosis.

Is NCT01065233 still recruiting?

NCT01065233 is currently completed. Last updated 17 September 2021.

Last reviewed 2021-09-17 · How we verify

NCT01065233: CDCHC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pangenomic Study During Alcoholic Cirrhosis

Completed Last updated 17 September 2021

What this trial tests

trial testing DNA extraction in Alcoholic Cirrhosis in 1,325 participants. Completed in 20 July 2013.

Timeline

23 October 2008

Primary endpoint
27 December 2011

20 July 2013

Quick facts

Lead sponsor	Nantes University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,325
Start date	23 October 2008
Primary completion	27 December 2011
Estimated completion	20 July 2013
Sites	4 locations across France

Drugs / interventions tested

DNA extraction

Conditions studied

Alcoholic Cirrhosis — all drugs for Alcoholic Cirrhosis →

Sponsor

Nantes University Hospital

Who can join

Adults 35 to 70, any sex, with Alcoholic Cirrhosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hepatocellular carcinoma (HCC) is a frequent complication of cirrhosis. Occurrence of HCC could be linked with multiple functional region of genome. The determining of a genomic mapping of " single nucleotide polymorphisms " (SNPs) permit to perform some genetic link studies with pathologies without clear hereditary disposition. In this study, the investigators will identify predictives genetic polymorphism of HCC.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Risk factors for hepatocellular carcinoma in Caucasian patients with non-viral cirrhosis: the importance of prior obesity.
Archambeaud I, Auble H, Nahon P, Planche L, et al · · 2015 · cited 14× · PMID 25522809 · DOI 10.1111/liv.12767

Verify or expand the search:

Other trials of DNA extraction

Trials testing the same drug.

NCT04561895 — Adipokine Genetic Variations in predictingNAFLD Progression to NASH in Egyptian Patients · completed
NCT04339725 — Gut Microbiota Metagenomics for Chronic Liver Disease · unknown
NCT03627780 — Genetic Polymorphism and Post Operative Nausea and Vomiting (PONV) · completed

Other recruiting trials for Alcoholic Cirrhosis

Currently open trials in the same condition.

NCT06866496 — Optimized Remission in Alcohol-related Liver Cirrhosis · NA · recruiting
NCT05093881 — Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study · NA · recruiting
NCT04689152 — Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis · Phase 3 · recruiting
NCT04250259 — SAMe Trial for Patients With Alcoholic Cirrhosis · Phase 2 · recruiting

Other Nantes University Hospital trials

Trials by the same sponsor.

NCT07278661 — Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. · Phase 2 · recruiting
NCT06681363 — Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelod · not yet recruiting
NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
NCT07490379 — Comparison of the Efficacy of Transcranial Direct Current Stimulation at Home Versus in Hospital Settings in Patients Wi · NA · not yet recruiting
NCT07423481 — Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01065233 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nantes University Hospital
Last refreshed: 17 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01065233.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing